8B)

8B). striking was that alginate encapsulation resulted in a much stronger differentiation compared to parallel two-dimensional cultures, resulting in 20-fold increase in c-peptide protein synthesis. To elucidate the mechanism contributing to encapsulation-mediated enhancement in hESC maturation, investigation of the signaling pathways revealed interesting insight. While the phospho-protein levels of all the tested signaling molecules were lower under encapsulation, the ratio of pSMAD/pAKT was significantly higher, indicating a more efficient transmission transduction under encapsulation. These results clearly demonstrate that alginate encapsulation of hESCs and differentiation to islet-cell types provides a potentially translatable treatment option for type 1 diabetes. == Introduction == It is well known thattype 1 diabetes constitutes 510% of all diabetes cases, wherein the immune system destroys the insulin-producing -cells of the pancreas.1Success of the Edmonton protocol has established islet transplantation as a EFNA1 promising diabetes therapy.2However, as with any other organ transplantation, with islet transplantations, patients were still required to be on regular immunosuppression treatments. As an alternative strategy, encapsulation of islets has been proposed to overcome the need for immunosuppressants. The encapsulation systems utilize materials that are permeable enough to allow the diffusion of glucose and other nutrients to the islets, and the diffusion of waste and insulin away from the islets, while masking the islets from your host immune response.36Alginate is a chemically inert nondegradable polymer, and most importantly it has the capability to immunoisolate encapsulated cells.7A simple and commonly used method to make sure whether alginate encapsulation provides sufficient immunoisolation for many cell types is the application of a polycationic covering, followed by an alginate coating.810These characteristics make it an ideal encapsulation system for islet transplantation, and thus it has been utilized for this purpose for decades.1119Although these methods of transplantation isolate the islets from your host immune response, this treatment option is plagued by shortage of donor islets. Specifically, approximately two to three pancreata worth of islets are necessary to return a diabetic patient to normoglycemia.20 A promising alternative to the whole organ or islet transplantation is the use of human embryonic stem cells (hESCs). Pluripotent stem cells have the potential to differentiate to any cell type in the body and are also in virtually unlimited Baloxavir marboxil supply, rendering hESC-derived islet-like cells a encouraging alternative to islets. Previous studies have focused on the induction of Baloxavir marboxil islet-like cells from hESCs primarily around the two-dimensional (2D) monolayer platform of tissue culture plastic (TCP).2124While these studies have been successful in deriving insulin-producing cells from embryonic stem cells, they are not directly scalable or translatable for type 1 diabetes treatment. The focus of our study, thus, is to establish the feasibility of obtaining encapsulated hESC-derived islet-like cells, which can be directly transplanted for diabetes therapy. While immunoisolation is the primary advantage of islet encapsulation, it offers the additional advantage of scalability for hESC-derived islets. The high throughput of encapsulation systems will allow the capability of generating the enormous quantity of pseudo-islets needed for tissue engineering applications. Encapsulation of embryonic stem cells has been an active area of research over the last decade. The majority of the efforts, however, had been restricted to mouse embryonic stem cells (mESCs) and its differentiation to numerous cell types.2527Since platforms established for Baloxavir marboxil mESCs cannot be directly translated to hESCs, targeted platforms need to be developed to handle issues associated with hESC encapsulation. Siti-Ismailet al.28have recently shown the feasibility of propagating hESCs encapsulated in calcium alginate for up to a period Baloxavir marboxil of 260 days. The encapsulated hESCs were reported to retain their characteristic pluripotency, and could be further induced to each specific germ layer. In another statement, Chayosumritet al.29have shown the feasibility of inducing definitive endoderm (DE) in encapsulated hESCs. Deanet al.30have shown that encapsulation of hESCs could prevent teratoma formation for up to 4 weeks after implantation into mice. Finally, Kimet al.31have used alginate encapsulation for differentiation of hESCs to midbrain dopamine-producing neurons. These initial studies clearly establish the potential benefits in encapsulating hESCs and demonstrate the feasibility of inducing early differentiation in these encapsulated hESCs. There have been no reports to date, however, to the best of our knowledge on exploiting encapsulation strategies for achieving late-stage differentiation of hESCs to the pancreatic lineage. The objective of the current work is thus to demonstrate for the first time the feasibility of generating hESC-derived islet-like cells under alginate encapsulation, which can be readily transplanted for diabetes therapy. In our.